Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT07687459 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07687459
- Sponsor
- InSilico Medicine Hong Kong Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-30
- Primary completion
- 2029-10-30
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.